H19 and acromegaly: Additionally, we evaluated whether H19 expression depends on the clinical characteristics of the patients, their treatment, tumour invasiveness, or prevalence of acromegaly comorbidities to explore if H19 RNA could be applied in prognostics and monitoring of the status of the disease and its complications.